Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

220 Views

Poster Session: HIV: Treatment

1263 - Dolutegravir/Rilpivirine Switch Study in Persons with HIV and Chronic Kidney Disease: 24-week Assessment of Viral Suppression, Adherence, Treatment Satisfaction and Quality of Life

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

HK

Helena Kwakwa, MD, MPH

Director of HIV Clinical Services
Philadelphia Department of Public Health
Philadelphia, Pennsylvania, United States

Co-Author(s)

OG

Oumar Gaye, MD, MPH

Philadelphia Department of Public Health
Philadelphia, Pennsylvania, United States
JR

Julia Ruff, R.N.

Newlands Health
Philadelphia, Pennsylvania, United States